Isabel Jiménez Bernal

Isabel Jiménez Bernal is a seasoned professional in the healthcare sector with extensive experience in investment analysis and biotech development. Currently serving as a Senior Investment Associate at Asabys Partners since July 2022, Isabel evaluates innovative investment opportunities. In addition, Isabel holds board observer roles at Augustine Therapeutics, Orikine Bio, and Cara Care, where contributions to the development of novel therapies and digital health solutions are made. Previous experience includes an investment analyst position at Ysios Capital and a research role at the Vall d´Hebron Institute of Oncology, where a PhD in Medicine was obtained. Isabel possesses an MBA from Esade and relevant degrees in advanced immunology and biochemistry from the Universitat Autònoma de Barcelona, Universitat de Barcelona, and Universidad de Zaragoza.